Date: Tue, 6 May 2003 13:44:30 +1000 From: JacobRhoden <jrhoden@unimelb.edu.au> To: Terry Lambert <tlambert2@mindspring.com>, Brett Glass <brett@lariat.org> Cc: chat@freebsd.org Subject: Re: open source license with 24 month proprietary clause Message-ID: <200305061344.30358.jrhoden@unimelb.edu.au> In-Reply-To: <3EB72E3B.1A77D437@mindspring.com> References: <4.3.2.7.2.20030504213212.03a5f140@localhost> <4.3.2.7.2.20030505082225.03cc5ec0@localhost> <3EB72E3B.1A77D437@mindspring.com>
next in thread | previous in thread | raw e-mail | index | archive | help
On Tue, 6 May 2003 01:38 pm, Terry Lambert wrote: > who needs long term treatment with your drug, > is worth a heck of a lot more long term revenue if you treat them > instead of curing them. That is true, but if you are the researcher working for the drug company, your motivation is not to make money for your company, you want to be the person that cured aids (no one remembers the person who helped temporarily alieve something) - jacob Jacob Rhoden Phone: +61 3 8344 6102 ITS Division Email: jrhoden@unimelb.edu.au Melbourne University Mobile: +61 403 788 386
Want to link to this message? Use this URL: <https://mail-archive.FreeBSD.org/cgi/mid.cgi?200305061344.30358.jrhoden>